TIDMCOS

Collagen Solutions PLC

29 August 2019

29 August 2019

Collagen Solutions plc

("Collagen Solutions" or the "Company")

ShareSoc Growth Company Seminar

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces will be presenting at the ShareSoc Growth Company Seminar in London on Wednesday, 11 September 2019.

Jamal Rushdy, CEO, will provide an update regarding progress highlighted during the recent Annual General Meeting, and the Company's prospects for growth.

The event will take place at the Offices of Link Asset Services, 65 Gresham Street, London EC2V 7NQ. Presentations will start at 5.30pm.

Further details of the event, along with a registration form, are available at:

https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-london-11-september-2019/

 
 Collagen Solutions Plc 
 Jamal Rushdy, CEO                                                Via Walbrook 
 Hilary Spence, CFO 
 
 Walbrook PR Ltd                 Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Anna Dunphy                                                Mob: 07876 741 001

About Collagen Solutions:

Collagen Solutions Plc is a global supplier, developer, and manufacturer of medical grade collagen, tissues, and related medical devices and components for use in regenerative medicine, tissue engineering, and research. The Company is also expanding its range of biomaterials-based finished medical devices based on its internal and acquired intellectual property for commercialisation with partners via licensing and distribution arrangements, including ChondroMimetic(R). The Company's products are used in a wide variety of applications including orthopaedics, cardiovascular, dental, plastic surgery, wound healing, neurology and urology.

For more information go to: www.collagensolutions.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRAFMGZRDRMGLZM

(END) Dow Jones Newswires

August 29, 2019 02:01 ET (06:01 GMT)

Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Healthcare Inv Charts.
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Healthcare Inv Charts.